Free Sarva Pharmaceuticals: International Expansion to Myanmar Case Study Solution | Assignment Help

Harvard Case - Sarva Pharmaceuticals: International Expansion to Myanmar

"Sarva Pharmaceuticals: International Expansion to Myanmar" Harvard business case study is written by Sandeep Puri, Sven Dahms, Shraddha Puri, Ritvik Nalamothu. It deals with the challenges in the field of Marketing. The case study is 8 page(s) long and it was first published on : Mar 17, 2020

At Fern Fort University, we recommend Sarva Pharmaceuticals pursue a phased approach to entering the Myanmar market, prioritizing the launch of essential generic medicines with a focus on affordability and accessibility. This strategy should leverage a strong digital marketing presence alongside traditional channels, emphasizing brand building through corporate social responsibility initiatives and partnerships with local healthcare providers.

2. Background

Sarva Pharmaceuticals, a leading Indian pharmaceutical company, is considering expanding into Myanmar, a rapidly growing market with a significant unmet need for affordable healthcare. The company faces several challenges, including a complex regulatory environment, limited infrastructure, and a competitive landscape dominated by international players.

The case study focuses on Mr. Sharma, Sarva's CEO, who is tasked with developing a strategic approach to entering the Myanmar market. He must consider the company's strengths, including its strong brand reputation, manufacturing capabilities, and expertise in generic drug production. However, he also needs to address the risks associated with entering a new and challenging market.

3. Analysis of the Case Study

To analyze Sarva's potential entry into Myanmar, we utilize a combination of frameworks:

1. SWOT Analysis:

  • Strengths: Strong brand reputation, established manufacturing capabilities, expertise in generic drug production, cost-effective operations.
  • Weaknesses: Lack of experience in emerging markets, limited understanding of Myanmar's healthcare system, potential challenges in navigating regulatory complexities.
  • Opportunities: Growing demand for affordable healthcare, increasing disposable income, potential for partnerships with local healthcare providers.
  • Threats: Competition from established international players, potential political instability, regulatory uncertainties, infrastructure limitations.

2. PESTEL Analysis:

  • Political: Myanmar's political landscape is undergoing significant changes, presenting both opportunities and risks.
  • Economic: The country's economy is growing rapidly, with increasing disposable income and a growing middle class.
  • Social: A large population with a growing need for healthcare, particularly for essential medicines.
  • Technological: Limited access to advanced technology and infrastructure, but potential for leveraging digital marketing and mobile technology.
  • Environmental: Limited environmental regulations, but a growing awareness of sustainability issues.
  • Legal: Complex regulatory environment, with strict requirements for drug registration and distribution.

3. Market Segmentation, Targeting, and Positioning:

  • Segmentation: Sarva should target different segments within the Myanmar market, including:
    • Low-income patients: Focus on essential generic medicines with affordable pricing.
    • Middle-income patients: Offer a wider range of products, including branded generics.
    • Hospitals and clinics: Build partnerships to ensure product availability and access.
  • Targeting: Sarva should prioritize its marketing efforts towards target segments through a mix of traditional and digital channels.
  • Positioning: Sarva should position itself as a reliable provider of high-quality, affordable medicines, emphasizing its commitment to improving healthcare accessibility in Myanmar.

4. Recommendations

Sarva Pharmaceuticals should adopt a phased approach to entering the Myanmar market:

Phase 1: Market Entry and Product Launch (Year 1)

  • Product Selection: Focus on launching a limited range of essential generic medicines with high demand and proven efficacy.
  • Pricing Strategy: Offer competitive pricing strategies to ensure affordability and accessibility.
  • Distribution Channels: Establish partnerships with local distributors and pharmacies to ensure widespread product availability.
  • Marketing Strategy: Focus on building brand awareness through a mix of digital marketing, social media campaigns, and collaborations with local healthcare providers.
  • Regulatory Compliance: Ensure full compliance with Myanmar's stringent regulatory requirements.

Phase 2: Market Expansion and Brand Building (Year 2-3)

  • Product Expansion: Gradually expand the product portfolio to include a wider range of generic medicines.
  • Brand Building: Develop a strong brand identity through targeted marketing campaigns, corporate social responsibility initiatives, and community outreach programs.
  • Customer Relationship Management: Implement CRM systems to build customer loyalty and gather valuable insights.
  • Technological Adoption: Leverage digital marketing tools and mobile technology to reach a wider audience and enhance customer engagement.

Phase 3: Sustainable Growth and Innovation (Year 4 onwards)

  • Innovation and Product Development: Invest in research and development to introduce new products and formulations tailored to the specific needs of the Myanmar market.
  • Strategic Partnerships: Explore strategic partnerships with local healthcare providers, pharmaceutical companies, and government agencies.
  • Corporate Social Responsibility: Integrate corporate social responsibility into the company's operations, focusing on initiatives that improve healthcare access and community well-being.
  • Long-Term Sustainability: Establish a sustainable business model that ensures long-term growth and profitability while contributing to the development of Myanmar's healthcare system.

5. Basis of Recommendations

These recommendations are based on the following considerations:

  • Core Competencies and Consistency with Mission: Sarva's expertise in generic drug production aligns with the need for affordable healthcare in Myanmar. The company's commitment to quality and affordability is central to its mission and resonates with the target market.
  • External Customers and Internal Clients: The recommendations prioritize the needs of both patients and healthcare providers, ensuring access to essential medicines and supporting the development of a robust healthcare system.
  • Competitors: The recommendations address the competitive landscape by focusing on differentiation through affordability, accessibility, and strong brand building.
  • Attractiveness ' Quantitative Measures: While the case study does not provide specific financial data, the recommendations prioritize a phased approach, minimizing risk and maximizing return on investment.

6. Conclusion

Sarva Pharmaceuticals has a strong opportunity to succeed in the Myanmar market by focusing on affordability, accessibility, and building a strong brand presence. By adopting a phased approach, leveraging digital marketing, and prioritizing corporate social responsibility, Sarva can establish itself as a trusted and reliable provider of essential medicines, contributing to the development of a healthier and more prosperous Myanmar.

7. Discussion

Alternatives:

  • Immediate full-scale entry: This approach carries higher risk but could potentially lead to faster market penetration.
  • Joint venture with a local partner: This could provide access to local expertise and networks but might limit control over operations.

Risks and Key Assumptions:

  • Political instability: Myanmar's political landscape is volatile, and any changes could impact business operations.
  • Regulatory challenges: The regulatory environment is complex and subject to change, requiring constant monitoring and adaptation.
  • Infrastructure limitations: Limited infrastructure could pose challenges for distribution and logistics.
  • Competition: Established international players pose significant competition, requiring a strong differentiation strategy.

Options Grid:

OptionAdvantagesDisadvantagesRisk
Phased approachLower risk, gradual investment, flexibility to adaptSlower market penetrationPolitical instability, regulatory changes
Immediate full-scale entryFaster market penetration, potential for higher market shareHigher risk, significant investment, potential for lossesPolitical instability, regulatory changes, competition
Joint venture with a local partnerAccess to local expertise and networks, reduced riskLimited control over operations, potential for conflictsCultural differences, lack of trust

8. Next Steps

Timeline:

  • Year 1: Conduct thorough market research, finalize product selection, secure regulatory approvals, establish distribution channels, launch initial marketing campaigns.
  • Year 2-3: Expand product portfolio, build brand awareness through targeted marketing and CSR initiatives, implement CRM systems, explore strategic partnerships.
  • Year 4 onwards: Invest in innovation and product development, focus on long-term sustainability, expand into new segments, and explore opportunities for regional expansion.

Key Milestones:

  • Q1 2024: Complete market research and finalize product selection.
  • Q2 2024: Secure regulatory approvals and establish distribution partnerships.
  • Q3 2024: Launch initial product line and marketing campaigns.
  • Q4 2024: Monitor market performance and adjust strategies as needed.

By following these recommendations and meticulously executing the outlined steps, Sarva Pharmaceuticals has a strong chance to achieve its international expansion goals in Myanmar, contributing to the improvement of healthcare access and the overall well-being of the country's population.

Hire an expert to write custom solution for HBR Marketing case study - Sarva Pharmaceuticals: International Expansion to Myanmar

more similar case solutions ...

Case Description

In 2019, the managing director of Sarva Pharmaceuticals Private Limited, a pharmaceutical company based in India, was considering an expansion of his company by entering the growing pharmaceutical market in Myanmar. He needed to identify the best way to execute this expansion plan, assess whether his company's product range was adequate and suitable for the Myanmar market, prepare for possible risks and cross-cultural marketing issues, and plan the management staffing approaches in Myanmar.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Write my custom case study solution for Harvard HBR case - Sarva Pharmaceuticals: International Expansion to Myanmar

Hire an expert to write custom solution for HBR Marketing case study - Sarva Pharmaceuticals: International Expansion to Myanmar

Sarva Pharmaceuticals: International Expansion to Myanmar FAQ

What are the qualifications of the writers handling the "Sarva Pharmaceuticals: International Expansion to Myanmar" case study?

Our writers hold advanced degrees in their respective fields, including MBAs and PhDs from top universities. They have extensive experience in writing and analyzing complex case studies such as " Sarva Pharmaceuticals: International Expansion to Myanmar ", ensuring high-quality, academically rigorous solutions.

How do you ensure confidentiality and security in handling client information?

We prioritize confidentiality by using secure data encryption, access controls, and strict privacy policies. Apart from an email, we don't collect any information from the client. So there is almost zero risk of breach at our end. Our financial transactions are done by Paypal on their website so all your information is very secure.

What is Fern Fort Univeristy's process for quality control and proofreading in case study solutions?

The Sarva Pharmaceuticals: International Expansion to Myanmar case study solution undergoes a rigorous quality control process, including multiple rounds of proofreading and editing by experts. We ensure that the content is accurate, well-structured, and free from errors before delivery.

Where can I find free case studies solution for Harvard HBR Strategy Case Studies?

At Fern Fort University provides free case studies solutions for a variety of Harvard HBR case studies. The free solutions are written to build "Wikipedia of case studies on internet". Custom solution services are written based on specific requirements. If free solution helps you with your task then feel free to donate a cup of coffee.

I’m looking for Harvard Business Case Studies Solution for Sarva Pharmaceuticals: International Expansion to Myanmar. Where can I get it?

You can find the case study solution of the HBR case study "Sarva Pharmaceuticals: International Expansion to Myanmar" at Fern Fort University.

Can I Buy Case Study Solution for Sarva Pharmaceuticals: International Expansion to Myanmar & Seek Case Study Help at Fern Fort University?

Yes, you can order your custom case study solution for the Harvard business case - "Sarva Pharmaceuticals: International Expansion to Myanmar" at Fern Fort University. You can get a comprehensive solution tailored to your requirements.

Can I hire someone only to analyze my Sarva Pharmaceuticals: International Expansion to Myanmar solution? I have written it, and I want an expert to go through it.

🎓 Struggling with term papers, essays, or Harvard case studies? Look no further! Fern Fort University offers top-quality, custom-written solutions tailored to your needs. Boost your grades and save time with expertly crafted content. Order now and experience academic excellence! 🌟📚 #MBA #HarvardCaseStudies #CustomEssays #AcademicSuccess #StudySmart Pay an expert to write my HBR study solution for the case study - Sarva Pharmaceuticals: International Expansion to Myanmar

Where can I find a case analysis for Harvard Business School or HBR Cases?

You can find the case study solution of the HBR case study "Sarva Pharmaceuticals: International Expansion to Myanmar" at Fern Fort University.

Which are some of the all-time best Harvard Review Case Studies?

Some of our all time favorite case studies are -

Can I Pay Someone To Solve My Case Study - "Sarva Pharmaceuticals: International Expansion to Myanmar"?

Yes, you can pay experts at Fern Fort University to write a custom case study solution that meets all your professional and academic needs.

Do I have to upload case material for the case study Sarva Pharmaceuticals: International Expansion to Myanmar to buy a custom case study solution?

We recommend to upload your case study because Harvard HBR case studies are updated regularly. So for custom solutions it helps to refer to the same document. The uploading of specific case materials for Sarva Pharmaceuticals: International Expansion to Myanmar ensures that the custom solution is aligned precisely with your needs. This helps our experts to deliver the most accurate, latest, and relevant solution.

What is a Case Research Method? How can it be applied to the Sarva Pharmaceuticals: International Expansion to Myanmar case study?

The Case Research Method involves in-depth analysis of a situation, identifying key issues, and proposing strategic solutions. For "Sarva Pharmaceuticals: International Expansion to Myanmar" case study, this method would be applied by examining the case’s context, challenges, and opportunities to provide a robust solution that aligns with academic rigor.

"I’m Seeking Help with Case Studies,” How can Fern Fort University help me with my case study assignments?

Fern Fort University offers comprehensive case study solutions, including writing, analysis, and consulting services. Whether you need help with strategy formulation, problem-solving, or academic compliance, their experts are equipped to assist with your assignments.

Achieve academic excellence with Fern Fort University! 🌟 We offer custom essays, term papers, and Harvard HBR business case studies solutions crafted by top-tier experts. Experience tailored solutions, uncompromised quality, and timely delivery. Elevate your academic performance with our trusted and confidential services. Visit Fern Fort University today! #AcademicSuccess #CustomEssays #MBA #CaseStudies

How do you handle tight deadlines for case study solutions?

We are adept at managing tight deadlines by allocating sufficient resources and prioritizing urgent projects. Our team works efficiently without compromising quality, ensuring that even last-minute requests are delivered on time

What if I need revisions or edits after receiving the case study solution?

We offer free revisions to ensure complete client satisfaction. If any adjustments are needed, our team will work closely with you to refine the solution until it meets your expectations.

How do you ensure that the case study solution is plagiarism-free?

All our case study solutions are crafted from scratch and thoroughly checked using advanced plagiarism detection software. We guarantee 100% originality in every solution delivered

How do you handle references and citations in the case study solutions?

We follow strict academic standards for references and citations, ensuring that all sources are properly credited according to the required citation style (APA, MLA, Chicago, etc.).

Hire an expert to write custom solution for HBR Marketing case study - Sarva Pharmaceuticals: International Expansion to Myanmar




Referrences & Bibliography for SWOT Analysis | SWOT Matrix | Strategic Management

1. Andrews, K. R. (1980). The concept of corporate strategy. Harvard Business Review, 61(3), 139-148.

2. Ansoff, H. I. (1957). Strategies for diversification. Harvard Business Review, 35(5), 113-124.

3. Brandenburger, A. M., & Nalebuff, B. J. (1995). The right game: Use game theory to shape strategy. Harvard Business Review, 73(4), 57-71.

4. Christensen, C. M., & Raynor, M. E. (2003). Why hard-nosed executives should care about management theory. Harvard Business Review, 81(9), 66-74.

5. Christensen, C. M., & Raynor, M. E. (2003). The innovator's solution: Creating and sustaining successful growth. Harvard Business Review Press.

6. D'Aveni, R. A. (1994). Hypercompetition: Managing the dynamics of strategic maneuvering. Harvard Business Review Press.

7. Ghemawat, P. (1991). Commitment: The dynamic of strategy. Harvard Business Review, 69(2), 78-91.

8. Ghemawat, P. (2002). Competition and business strategy in historical perspective. Business History Review, 76(1), 37-74.

9. Hamel, G., & Prahalad, C. K. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

10. Kaplan, R. S., & Norton, D. P. (1992). The balanced scorecard--measures that drive performance. Harvard Business Review, 70(1), 71-79.

11. Kim, W. C., & Mauborgne, R. (2004). Blue ocean strategy. Harvard Business Review, 82(10), 76-84.

12. Kotter, J. P. (1995). Leading change: Why transformation efforts fail. Harvard Business Review, 73(2), 59-67.

13. Mintzberg, H., Ahlstrand, B., & Lampel, J. (2008). Strategy safari: A guided tour through the wilds of strategic management. Harvard Business Press.

14. Porter, M. E. (1979). How competitive forces shape strategy. Harvard Business Review, 57(2), 137-145.

15. Porter, M. E. (1980). Competitive strategy: Techniques for analyzing industries and competitors. Simon and Schuster.

16. Porter, M. E. (1985). Competitive advantage: Creating and sustaining superior performance. Free Press.

17. Prahalad, C. K., & Hamel, G. (1990). The core competence of the corporation. Harvard Business Review, 68(3), 79-91.

18. Rumelt, R. P. (1979). Evaluation of strategy: Theory and models. Strategic Management Journal, 1(1), 107-126.

19. Rumelt, R. P. (1984). Towards a strategic theory of the firm. Competitive Strategic Management, 556-570.

20. Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509-533.